デフォルト表紙
市場調査レポート
商品コード
963974

微結晶性セルロース (MCC)の世界市場:成長、動向、予測(2021年~2026年)

Microcrystalline Cellulose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.27円
微結晶性セルロース (MCC)の世界市場:成長、動向、予測(2021年~2026年)
出版日: 2021年05月13日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

微結晶性セルロースの市場規模は、予測期間中に6%以上のCAGRで成長すると予測されています。市場を牽引する主な要因の一つは、世界の重要な経済圏全体で製薬業界からの微結晶性セルロースに対する需要の高まりです。ただし、微結晶性セルロースの高い製造コストは、市場の成長を妨げると予想されます。

  • エンドユーザー産業別では、製薬業界が予測期間にわたって市場を独占すると予想されます。
  • キャンバスのライニング接着剤としての微結晶性セルロース複合材料の需要の高まりは、今後数年間で市場の機会として機能する可能性があります。
  • アジア太平洋は、インドや中国などの国で製薬業界からの製造が増加することで市場を独占すると予想されます。

当レポートでは微結晶性セルロースの世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、原料・プロセス・エンドユーザー産業・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因
    • 製薬業界からの需要の高まり
    • その他
  • 抑制要因
    • 高い製造コスト
    • その他
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • プロセス分析

第5章 市場セグメンテーション

  • 原料別
    • 木ベース
    • 非木材ベース
  • プロセス別
    • 反応性押し出し
    • 酵素媒介
    • 蒸気爆発
    • 酸加水分解
  • エンドユーザー産業別
    • 製薬
    • 食物
    • 化粧品
    • その他
  • 地域別
    • アジア太平洋
    • 北米
    • 欧州
    • 南米
    • 中東とアフリカ

第6章 競合情勢

  • 合併と買収、合弁事業、コラボレーション、合意
  • Market Share/Ranking Analysis**
  • 主要企業が採用した戦略
  • 企業プロファイル
    • Chemfield Cellulose
    • Accent Microcell Pvt. Ltd
    • FMC Corporation
    • Sigachi Industries Pvt. Ltd
    • DuPont
    • MINGTAI CHEMICAL CO. LTD
    • Asahi Kasei Corporation
    • Juku Orchem Pvt. Ltd
    • J. Rettenmaier & Sohne GmbH + Co. KG
    • Huzhou City Linghu Xinwang Chemical Co. Ltd
    • Avantor Performance Materials Inc.
    • DFE Pharma GmbH & Co.KG
    • Blanver
    • Gujarat Microwax Limited
    • FrieslandCampina

第7章 市場機会と動向

  • 帆布のライニング接着剤としての微結晶性セルロース複合材料の需要の高まり
  • その他の機会
目次
Product Code: 69486

The Global Microcrystalline Cellulose Market is projected to register a CAGR of over 6% during the forecast period (2021-2026).

Pharmaceutical and cosmetics are the major end-user industries of microcrystalline cellulose. The ongoing coronavirus (COVID-19) pandemic has altered the face of the beauty industry. As a result of months of consumer lockdowns, international travel bans, and retail business closures, sales, purchases, and usage have fallen across many beauty segments. However, the pharmaceutical industry experienced an increase in production due to the COVID-19 pandemic as the medicines used in hospitals around the world have increased thus increasing the demand for microcrystalline cellulose which is used in the production of drugs. Furthermore, government support in various countries in the pharmaceutical sector is expected positively influence the market studied. For instance, in 2021, in India, the government has approved 19 applications with committed investments of INR 4623.01 crore under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs).

  • Over the short term, the growing demand for microcrystalline cellulose from the pharmaceutical industry across significant economies of the world is expected to drive the demand for the market studied.
  • On the flipside, the high manufacturing and production cost of microcrystalline cellulose is expected to hinder the growth of the market studied.
  • The Asia-Pacific region is expected to dominate the market with increasing manufacturing from the pharmaceutical industry in countries like India and China.

Key Market Trends

Increasing Demand from Pharmaceutical Industry

  • Microcrystalline cellulose (MCC) is a pure partially depolymerized cellulose synthesized from α-cellulose precursor (type IB), obtained as a pulp from fibrous plant material, with mineral acids using hydrochloric acid to reduce the degree of polymerization.
  • Microcrystalline cellulose is a commonly used excipient in the pharmaceutical industry. It has excellent compressibility properties and is used in solid dose forms, such as tablets, and is the most widely used direct compression excipient, acting as a strong dry binder, tablet disintegrant, absorbent, filler or diluent, lubricant, and anti-adherent.
  • MCC is widely regarded as the diluent with the best binding properties, and it is one of the most commonly used direct compression binders.
  • It is used as a binder/diluent in both wet granulation and direct compression processes for oral tablet and capsule formulations. It also has lubricant and disintegrant properties, making it ideal for direct tableting.
  • The factors such as disease prevalence, affordability, consumer's attitude, government (and insurance company) policies, and available supply of medicines boost the pharmaceutical industry, which, in turn, increases the demand for microcrystalline cellulose.
  • Global pharmaceutical industry is increasing with growing production in countries such as United States, China and India. India is a prominent and rapidly growing market for pharmaceuticals. It has largest number of US-FDA compliant Pharma plants (more than 262 including APIs) outside of USA and has more than 2000 WHO-GMP approved Pharma Plants, 253 European Directorate of Quality Medicines (EDQM) approved plants with modern state of the art Technology.
  • Moreover, the companies are also planning to invest across the globe amid increasing demand of pharmaceuticals worldwide. For instance, in December 2020, an Indian company, Piramal Pharma Solutions announced its plans to invest USD 32 million to expand its facility in Michigan, the United States, with additional capacity and new capabilities for development and manufacturing of active pharmaceutical ingredients.
  • Hence, owing to the factors mentioned above, the application of microcrystalline cellulose from the pharmaceutical industry is likely to increase during the forecast period.

Asia-Pacific to Dominate the Market

  • The Asia-Pacific region is expected to dominate the market during the forecast period. The rising demand for microcrystalline cellulose from pharmaceutical and cosmetics industries in countries like China and India is expected to drive the demand for microcrystalline cellulose in this region.
  • According to Invest India, the pharmaceutical industry in India is expected to reach USD 65 billion by 2024 and is currently valued at USD 41 billion.
  • The largest producers of microcrystalline cellulose are based in the Asia-Pacific region. Some of the leading companies in the production of microcrystalline cellulose are Sigachi Industries Pvt. Ltd, Huzhou City Linghu Xinwang Chemical Co. Ltd, DuPont, Asahi Kasei Corporation, and J. Rettenmaier & Sohne GmbH + Co. KG, among others.
  • According to L'Oreal data, the global cosmetic market, which is valued at more than EUR 220 billion, grew by more than 5.5% in 2019, with sales from online platforms gaining the highest momentum, of more than 25% during the same year. This growth is majorly spurred on in the Asia-Pacific region by the limitless diversity of consumer aspirations and owing to the continuous innovations in the industry. Asia-Pacific has the highest demand for cosmetics, particularly luxury products. The region accounted for over half of the skincare market.
  • South Korea has one of the world's most exceptional beauty markets. New beauty trends and innovations, featuring sophisticated ingredients and aesthetically-appealing packaging, are constantly on display. The South Korean cosmetics products market was valued at USD 1,578.4 million in 2019, and it is expected to reach USD 1952.05 million by 2025 during the forecast period, 2020-2025.
  • Owing to the factors mentioned above, the market for microcrystalline cellulose in the Asia-Pacific region is projected to grow significantly during the study period.

Competitive Landscape

The microcrystalline cellulose market is partially fragmented in nature, with only a few major players dominating the market. Some of the major companies of the market studied include DuPont, Chemfield Cellulose, Accent Microcell, Sigachi Industries Limited, and DFE Pharma, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing Demand for Microcrystalline Cellulose from Pharmaceutical Industry
    • 4.1.2 Other Drivers
  • 4.2 Restraints
    • 4.2.1 High Manufacturing and Production Cost
    • 4.2.2 Impact of COVID-19 on Cosmetics Industry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Degree of Competition
  • 4.5 Process Analysis

5 MARKET SEGMENTATION

  • 5.1 Source
    • 5.1.1 Wood-based
    • 5.1.2 Non -wood-based
  • 5.2 Process
    • 5.2.1 Reactive Extrusion
    • 5.2.2 Enzyme Mediated
    • 5.2.3 Steam Explosion
    • 5.2.4 Acid Hydrolysis
  • 5.3 End-User Industry
    • 5.3.1 Pharmaceutical
    • 5.3.2 Food
    • 5.3.3 Cosmetics
    • 5.3.4 Other End-User Industries
  • 5.4 Geography
    • 5.4.1 Asia-Pacific
      • 5.4.1.1 China
      • 5.4.1.2 India
      • 5.4.1.3 Japan
      • 5.4.1.4 South Korea
      • 5.4.1.5 Rest of Asia-Pacific
    • 5.4.2 North America
      • 5.4.2.1 United States
      • 5.4.2.2 Canada
      • 5.4.2.3 Mexico
    • 5.4.3 Europe
      • 5.4.3.1 Germany
      • 5.4.3.2 United Kingdom
      • 5.4.3.3 France
      • 5.4.3.4 Italy
      • 5.4.3.5 Rest of Europe
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle-East and Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 South Africa
      • 5.4.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)** /Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Accent Microcell
    • 6.4.2 Asahi Kasei Corporation
    • 6.4.3 Blanver
    • 6.4.4 Chemfield Cellulose
    • 6.4.5 DFE Pharma
    • 6.4.6 DuPont
    • 6.4.7 GUJARAT MICROWAX PVT. LTD.
    • 6.4.8 Huzhou City Linghu Xinwang Chemical Co., Ltd
    • 6.4.9 J. RETTENMAIER & SOHNE GmbH + Co KG
    • 6.4.10 JUKU ORCHEM PVT. LTD.
    • 6.4.11 MINGTAI CHEMICAL CO., LTD
    • 6.4.12 Sigachi Industries Limited
    • 6.4.13 VWR International, LLC (Avantor, Inc.)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Growing Demand of Microcrystalline Cellulose Composites as Lining Adhesives for Canvas
  • 7.2 Other Opportunities